Distinct radiosensitivity of lung carcinoma stem-like side population and main population cells

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 6, 2013, Pages 471-478

  Xia, Pu ^a   Gou, Wen Feng ^a   Wang, Jin Jin ^b   Niu, Ze Feng ^a   Chen, Shuo ^a   Takano, Yasuo ^c   Zheng, Hua Chuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Yanda International Medical Research Institute   (China)

^c KANAGAWA CANCER CENTER   (Japan)

Author keywords

Apoptosis; Cancer stem like main population cells; Cancer stem like side population cells; Growth; Lewis lung carcinoma; Mitochondrial damage; Radiosensitivity

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CASPASE 3; CASPASE 9; CD133 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CARCINOMA CELL; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; IN VIVO STUDY; IONIZING RADIATION; LEWIS CARCINOMA; LUNG CARCINOMA; MAIN POPULATION CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE POPULATION CELL; STEM CELL; WESTERN BLOTTING;

APOPTOSIS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84880907810     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1388     Document Type: Article

References (47)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69.
2. Mairs RJ, Fullerton NE, Zalutsky MR, et al. Targeted radiotherapy: Microgray doses and the bystander effect. Dose Response 2007;5:204.
3. Prise KM, O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 2009;9:351.
4. El-Deiry WS. The role of p53 in chemosensitivity and radiosensitivity. Oncogene 2003;22:7486.
5. West KA, Brognard J, Clark AS, et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003;111:81.
6. Klonisch T, Wiechec E, Hombach-Klonisch S, et al. Cancer stem cell markers in common cancers-therapeutic implications. Trends Mol Med 2000;14:450.
7. Dingli D, Michor F. Successful therapy must eradicate cancer stem cells. Stem Cells 2006;24:2603.
8. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730.
9. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396.
10. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005;65:5506.
11. Patrawala L, Calhoun T, Schneider-Broussard R, et al. Highly purified CD44 + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006;25:1696.
12. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 2004;101:781.
13. Wu C, Wei Q, Utomo V, et al. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res 2007;67:8216.
14. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci U S A 2006;103:11154.
15. Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008;15:504.
16. Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007;132:2542.
17. Haraguchi N, Ohkuma M, Sakashita H, et al. CD133 + CD44 + population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 2008;15:2927.
18. Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946.
19. Immervoll H, Hoem D, Sakariassen PØ, et al. Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer 2008;8:48.
20. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:44.
21. Crack PJ, Taylor JM. Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 2005;38:1433.
22. Ermak G, Davies KJ. Calcium and oxidative stress: From cell signaling to cell death. Mol Immunol 2002;38:713.
23. Simbula G, Columbano A, Ledda-Columbano GM, et al. Increased ROS generation and p53 activation in alphalipoic acidinduced apoptosis of hepatoma cells. Apoptosis 2007;12:113.
24. Reinecke F, Levanets O, Olivier Y, et al. Metallothionein isoform 2A expression is inducible and protects against ROS-mediated cell death in rotenone-treated HeLa cells. Biochem J 2006;395:405.
25. Yang J, Wu JN, Tashiro S, et al. Critical roles of reactive oxygen species in mitochondrial permeability transition in mediating evodiamine-induced human melanoma A375-S2 cell apoptosis. Free Radic Res 2007;41:1099.
26. Huang DC, Strasser A. BH3-Only proteins-essential initiators of apoptotic cell death. Cell 2000;103:839.
27. Yang ML, Huang TS, Lee Y, et al. Free radical scavenging properties of sulfinpyrazone. Free Radic Res 2000;6:685.
28. Adams JM, Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science 1998;281:1322.
29. Wang ZB, Liu YQ, Cui YF. Pathways to caspase activation. Cell Biol Int 2005;29:489.
30. Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001;7:1028.
31. Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 2004;101:14228.
32. Bussolati B, Bruno S, Grange C, et al. Identification of a tumor-initiating stem cell population in human renal carcinomas. FASEB J 2008;22:3696.
33. Liu ZH, Lenardo MJ. Reactive oxygen species regulate autophagy through redox-sensitive proteases. Dev Cell 2007;12:484.
34. Raff M. Cell suicide for beginners. Nature 1998;396:119.
35. Yu F, Watts RN, Zhang XD, et al. Involvement of BH3-only proapoptotic proteins in mitochondrial-dependent Phenoxodiol-induced apoptosis of human melanoma cells. Anticancer Drugs 2006;17:1151.
36. Criollo A, Galluzzi L, Maiuri MC, et al. Mitochondrial control of cell death induced by hyperosmotic stress. Apoptosis 2007;1:3.
37. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44 + breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006;98:1777.
38. Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: Apoptosomes and mitochondrial. Genes Cell 1998;3:697.
39. Woodward WA, Chen MS, Behbod F, et al. WNT/betacatenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A 2007;104: 618.
40. Kim H, Rafiuddin-Shah M, Tu HC, et al. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 2006;8:1348.
41. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756.
42. Maynard S, Swistowska AM, Lee JW, et al. Human embryonic stem cells have enhanced repair of multiple forms of DNA damage. Stem Cells 2008;26:2266.
43. López J, Poitevin A, Mendoza-Martínez V, et al. Cancerinitiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer 2012;12:48.
44. Su W, Chen Y, Zeng W, et al. Involvement of Wnt signaling in the injury of murine mesenchymal stem cells exposed to x-radiation. Int J Radiat Biol 2012;88:635.
45. Yu S, Zhang R, Liu F, et al. Notch inhibition suppresses nasopharyngeal carcinoma by depleting cancer stem-like side population cells. Oncol Rep 2012;28:561.
46. Tong XZ, Wang F, Liang S, et al. Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells. Biochem Pharmacol 2012;83:586.
47. Misawa A, Katayama R, Koike S, et al. AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells. Oncol Res 2012;19:23.